awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33399101-8D2DE65F-6B19-4ABF-85E7-4B20006D3A74
Q33399101-8D2DE65F-6B19-4ABF-85E7-4B20006D3A74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399101-8D2DE65F-6B19-4ABF-85E7-4B20006D3A74
Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
P2860
Q33399101-8D2DE65F-6B19-4ABF-85E7-4B20006D3A74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399101-8D2DE65F-6B19-4ABF-85E7-4B20006D3A74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5018e1e05affc3f4ede3898995c0c5a1cda217f8
P2860
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).